Key result
Higher membrane lung dead space was significantly associated with ECMO failure, demonstrating a 2.61-fold increase in the odds of circuit exchange for every 0.05-unit increase.
Why the study?
Veno-venous ECMO membrane lungs deteriorate over time due to prothrombotic activation, and existing single clinical indicators lack sufficient power to predict sudden ECMO mechanical failure.
Does membrane lung dead space predict sudden ECMO mechanical failure in patients with refractory respiratory failure on veno-venous ECMO?
Observational (n=20)
No
Does membrane lung dead space predict sudden ECMO mechanical failure in patients with refractory respiratory failure on veno-venous ECMO?
This pilot study aims to evaluate if membrane lung dead space can serve as a reliable, quantifiable predictor of sudden ECMO mechanical failure.
May support membrane lung monitoring in VV-ECMO; hypothesis-generating pilot data requiring prospective validation before practice change.
Veno-venous ECMO respiratory assistance is a milestone treatment in refractory respiratory failure and may provide sufficient respiratory assistance in patients with deranged lung functions. Despite its crucial role in patient survival, especially in an acute respiratory distress syndrome (ARDS) setting, veno-venous ECMO leads to a systemic inflammatory state resulting in prothrombotic activation that gives rise to the deterioration of the extracorporeal membrane lung itself. This derangement eventually leads to sudden ECMO mechanical failure exposing the patient to severe hypoxemia, which can have fast and dramatic consequences. For these reasons, we measured a number of parameters (such as membrane lung pressure drop and partial oxygen pressure in blood at the outflow tract of the membrane lung) to try to predict the possibility of a sudden ECMO failure. None of these indicators alone seems to have significant power in the clinical setting. Considering membrane lung physiology, we built a pilot study to explore the behavior of membrane lung dead space as a possible quantifiable indicator of membrane lung efficiency and as a reliable predictor of ECMO failure.
No takes yet. Share an insight, caveat, or question.
Lino et al. (2023) conducted an observational in COVID-19 ARDS requiring veno-venous ECMO (n=20). Membrane lung dead space (MLDS) vs. Lower MLDS was evaluated on ECMO circuit exchange due to mechanical failure (OR 2.61, 95% CI 1.16-5.89, p=<0.0001). Higher membrane lung dead space was significantly associated with ECMO failure, demonstrating a 2.61-fold increase in the odds of circuit exchange for every 0.05-unit increase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: